Macrophages promote matrix protrusive and invasive function of breast cancer cells via MIP-1β dependent upregulation of MYO3A gene in breast cancer cells

References

• Bendre M, Gaddy D, Nicholas RW, Suva LJ. Breast cancer metastasis to bone: it is not all about PTHrP. Clin Orthop Relat Res 2003; (415 Suppl):S39-45; PMID:14600591; http://dx.doi.org/10.1097/01.blo.0000093844.72468.f4
   PubMedGoogle Scholar
• Eckert MA, Yang J. Targeting invadopodia to block breast cancer metastasis. Oncotarget 2011; 2(7):562-8; PMID:21725138; http://dx.doi.org/10.18632/oncotarget.301
   PubMed Web of Science ®Google Scholar
• Viadana E, Bross ID, Pickren JW. An autopsy study of the metastatic patterns of human leukemias. Oncology 1978; 35(2):87-96; PMID:274679; http://dx.doi.org/10.1159/000225262
   PubMed Web of Science ®Google Scholar
• Shaffrey ME, Mut M, Asher AL, Burri SH, Chahlavi A, Chang SM, Farace E, Fiveash JB, Lang FF, Lopes MB et al. Brain metastases. Curr Probl Surg 2004; 41(8):665-741; PMID:15354117; http://dx.doi.org/10.1067/j.cpsurg.2004.06.001
   PubMed Web of Science ®Google Scholar
• Sica A, Schioppa T, Mantovani A, Allavena P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 2006; 42(6):717-27; PMID:16520032; http://dx.doi.org/10.1016/j.ejca.2006.01.003
   PubMed Web of Science ®Google Scholar
• Mueller MM, Fusenig NE. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004; 4(11):839-49; PMID:15516957; http://dx.doi.org/10.1038/nrc1477
   PubMed Web of Science ®Google Scholar
• Wang R, Chadalavada K, Wilshire J, Kowalik U, Hovinga KE, Geber A, Fligelman B, Leversha M, Brennan C, Tabar V. Glioblastoma stem-like cells give rise to tumour endothelium. Nature 2010; 468(7325):829-33; PMID:21102433; http://dx.doi.org/10.1038/nature09624
   PubMed Web of Science ®Google Scholar
• Tripathi C, Tewari BN, Kanchan RK, Baghel KS, Nautiyal N, Shrivastava R, Kaur H, Bhatt ML, Bhadauria S. Macrophages are recruited to hypoxic tumor areas and acquire a pro-angiogenic M2-polarized phenotype via hypoxic cancer cell derived cytokines Oncostatin M and Eotaxin. Oncotarget 2014; 5(14):5350-68; PMID:25051364; http://dx.doi.org/10.18632/oncotarget.2110
   PubMed Web of Science ®Google Scholar
• Welford AF, Biziato D, Coffelt SB, Nucera S, Fisher M, Pucci F, Di Serio C, Naldini L, De Palma M, Tozer GM et al. TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice. J Clin Invest 2011; 121(5):1969-73; PMID:21490397; http://dx.doi.org/10.1172/JCI44562
   PubMed Web of Science ®Google Scholar
• Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002; 196(3):254-65; PMID:11857487; http://dx.doi.org/10.1002/path.1027
   PubMed Web of Science ®Google Scholar
• Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002; 2(8):563-72; PMID:12154349; http://dx.doi.org/10.1038/nrc865
   PubMed Web of Science ®Google Scholar
• Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009; 9(4):239-52; PMID:19279573; http://dx.doi.org/10.1038/nrc2618
   PubMed Web of Science ®Google Scholar
• Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med 2013; 19(11):1423-37; PMID:24202395; http://dx.doi.org/10.1038/nm.3394
   PubMed Web of Science ®Google Scholar
• Maurer M, von Stebut E. Macrophage inflammatory protein-1. Int J Biochem Cell Biol 2004; 36(10):1882-6; PMID:15203102; http://dx.doi.org/10.1016/j.biocel.2003.10.019
   PubMed Web of Science ®Google Scholar
• Walsh T, Walsh V, Vreugde S, Hertzano R, Shahin H, Haika S, Lee MK, Kanaan M, King MC, Avraham KB. From flies' eyes to our ears: mutations in a human class III myosin cause progressive nonsyndromic hearing loss DFNB30. Proc Natl Acad Sci USA 2002; 99(11):7518-23; PMID:12032315; http://dx.doi.org/10.1073/pnas.102091699
   PubMed Web of Science ®Google Scholar
• Pichot CS, Arvanitis C, Hartig SM, Jensen SA, Bechill J, Marzouk S, Yu J, Frost JA, Corey SJ. Cdc42-interacting protein 4 promotes breast cancer cell invasion and formation of invadopodia through activation of N-WASp. Cancer Res 2010; 70(21):8347-56; PMID:20940394; http://dx.doi.org/10.1158/0008-5472.CAN-09-4149
   PubMed Web of Science ®Google Scholar
• Balassarre M, Pompeo A, Beznoussenko G, Castaldi C, Cortellino S, McNiven MA, Luini A, Buccione R. Dynamin participates in focal extracellular matrix degradation by invasive cells. Mol Biol Cell 2003; 14(3):1074-84; PMID:12631724; http://dx.doi.org/10.1091/mbc.E02-05-0308
   PubMed Web of Science ®Google Scholar
• Buday L, Downward J. Roles of cortactin in tumor pathogenesis. Biochim Biophys Acta 2007; 1775(2):263-73; PMID:17292556; http://dx.doi.org/10.1016/j.bbcan.2006.12.002
   PubMed Web of Science ®Google Scholar
• Weaver AM. Cortactin in tumor invasiveness. Cancer Lett 2008; 265(2):157-66; PMID:18406052; http://dx.doi.org/10.1016/j.canlet.2008.02.066
   PubMed Web of Science ®Google Scholar
• MacGrath SM, Koleske AJ. Cortactin in cell migration and cancer at a glance. J Cell Sci 2012; 125(Pt 7):1621-6; PMID:22566665; http://dx.doi.org/10.1242/jcs.093781
   PubMed Web of Science ®Google Scholar
• Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller SC. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res 2006; 66(6):3034-43; PMID:16540652; http://dx.doi.org/10.1158/0008-5472.CAN-05-2177
   PubMed Web of Science ®Google Scholar
• Ayala I, Baldassarre M, Giacchetti G, Caldieri G, Tetè S, Luini A, Buccione R. Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation. J Cell Sci 2008; 121(Pt 3):369-78; PMID:18198194; http://dx.doi.org/10.1242/jcs.008037
   PubMed Web of Science ®Google Scholar
• Combadiere C, Ahuja SK, Tiffany HL, Murphy PM. Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1(α), MIP-1(β), and RANTES. J Leukoc Biol 1996; 60(1):147-52; PMID:8699119
   PubMed Web of Science ®Google Scholar
• Alexander SPH, Mathie A, Peters JA. Chemokine. Br J Pharmacol. 2006; S26-S28; http://dx.doi.org/10.1038/sj.bjp.0706562
   Google Scholar
• Lewis C, Murdoch C. Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. Am J Pathol 2005; 167(3):627-35; PMID:16127144; http://dx.doi.org/10.1016/S0002-9440(10)62038-X
   PubMed Web of Science ®Google Scholar
• Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001; 17:463-516; PMID:11687497; http://dx.doi.org/10.1146/annurev.cellbio.17.1.463
   PubMed Web of Science ®Google Scholar
• Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2(3):161-74; PMID:11990853; http://dx.doi.org/10.1038/nrc745
   PubMed Web of Science ®Google Scholar
• Lynch CC, Matrisian LM. Matrix metalloproteinases in tumor-host cell communication. Differentiation 2002; 70(9-10):561-73; PMID:12492497; http://dx.doi.org/10.1046/j.1432-0436.2002.700909.x
   PubMed Web of Science ®Google Scholar
• Fingleton B. Matrix metalloproteinases: roles in cancer and metastasis. Front Bio Sci 2006; 11:479-91; PMID:16146745; http://dx.doi.org/10.2741/1811
   PubMed Web of Science ®Google Scholar
• Gordon GJ, Rockwell GN, Jensen RV, Rheinwald JG, Glickman JN, Aronson JP, Pottorf BJ, Nitz MD, Richards WG, Sugarbaker DJ et al. Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling. Am J Pathol 2005; 166 (6):1827-40; PMID:15920167; http://dx.doi.org/10.1016/S0002-9440(10)62492-3
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25(12):677-86; PMID:15530839; http://dx.doi.org/10.1016/j.it.2004.09.015
   PubMed Web of Science ®Google Scholar
• Yuan A, Hsiao YJ, Chen HY, Chen HW, Ho CC, Chen YY, Liu YC, Hong TH, Yu SL, Chen JJ et al. Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression. Sci Rep 2015; 5:14273; PMID:26399191; http://dx.doi.org/10.1038/srep14273
   PubMed Web of Science ®Google Scholar
• Biswas SK, Sica A, Lewis CE. Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J Immunol 2008; 180(4):2011-7; PMID:18250403; http://dx.doi.org/10.4049/jimmunol.180.4.2011
   PubMed Web of Science ®Google Scholar
• Shih JY, Yuan A, Chen JJW, Yang PC. Tumor-associated macrophage: its role in cancer invasion and metastasis. J Cancer Mol 2006; 2:101-6
   Google Scholar
• Paz H, Pathak N, Yang J. Invading one step at a time: the role of invadopodia in tumor metastasis. Oncogene 2014; 33:4193-202; PMID:24077283; http://dx.doi.org/10.1038/onc.2013.393
   PubMed Web of Science ®Google Scholar
• Luo X, Yu Y, Liang A, Xie Y, Liu S, Guo J, Wang W, Qi R, An H, Zhang M et al. Intratumoral expression of MIP-1beta induces antitumor responses in a pre-established tumor model through chemoattracting T cells and NK cells. Cell Mol Immunol 2004; 1(3):199-204; PMID:16219168
   PubMed Web of Science ®Google Scholar
• Kerber ML, Cheney RE. Myosin-X: a MyTH-FERM myosin at the tips of filopodia. J Cell Sci 2011; 124(Pt 22):3733-41; PMID:22124140; http://dx.doi.org/10.1242/jcs.023549
   PubMed Web of Science ®Google Scholar
• Daigneault M, Preston JA, Marriott HM, Whyte MK, Dockrell DH. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One 2010; 5(1):e8668; PMID:20084270; http://dx.doi.org/10.1371/journal.pone.0008668
   PubMed Web of Science ®Google Scholar
• Artym VV, Yamada KM, Mueller SC. ECM degradation assays for analyzing local cell invasion. Methods Mol Biol 2009; 522:211-9; PMID:19247615; http://dx.doi.org/10.1007/978-1-59745-413-1_15
   PubMedGoogle Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193(1):265-75; PMID:14907713; http://dx.doi.org/10.1016/0304-3894(92)87011-4
   PubMed Web of Science ®Google Scholar
• Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29(9):e45; PMID:11328886; http://dx.doi.org/10.1093/nar/29.9.e45
   PubMed Web of Science ®Google Scholar
• Wilson SM, Chambers AF. Experimental metastasis assays in the chick embryo. Curr Protoc Cell Biol 2004; Chapter 19: Unit 19.6; PMID:18228449; http://dx.doi.org/10.1002/0471143030.cb1906s21
   PubMedGoogle Scholar